Overview
- The CDC moved vaccines for COVID-19, influenza, hepatitis A, hepatitis B, rotavirus and meningococcal disease out of universal recommendations and into high-risk or shared clinical decision-making categories.
- Career CDC scientists say they were excluded and the Advisory Committee on Immunization Practices was not consulted, drawing condemnation from major medical organizations that urged a reversal.
- Several states, including California, Maryland, Illinois, Minnesota and Pennsylvania, said they will continue following the American Academy of Pediatrics’ full schedule, with officials in places like Massachusetts affirming school-entry requirements remain unchanged.
- Federal officials and major insurers said affected vaccines remain available without out-of-pocket costs through 2026, though experts note pharmacy and clinic workflows may make access more difficult.
- Public health experts warn the shift will fuel confusion and lower vaccination rates, with added concern for day-care illness and equity, as HHS Secretary Robert F. Kennedy Jr. defended the changes and said fewer flu shots for children might be preferable during a severe flu season.